News

As we begin our annual health care recap series this month, let's take a look back at the stories our readers liked most.

RBX2660 is the first live microbiota therapeutic approved by the FDA.

A recent quality improvement study demonstrated the potential to enhance ophthalmic telehealth using asynchronous testing, which was effective in subspecialty-level care.

The strongest confounders were family income, caregiver education, and ADHD polygenic risk scores for ADHD clinical range diagnoses.

This brain imaging study was the first to look at the position of depression and systemic inflammation in brain measures while including the largest sample of patients with psoriasis to date.

The study data indicate high early-stage CRT variability showed a significantly higher risk of legal blindness.

The product is administered as a single dose and is manufactured using the stool of qualified donors.

Inflammatory diseases like psoriasis, as well as lupus erythematosus and rheumatoid arthritis, can lead to systemic chronic inflammation followed by other complications.

The study reported 6.1% of study patients with NTG had ODD diagnosed using EDI-OCT, compared to the 1.8% – 2.0% reported in the general population.

Low luminance contrast sensitivity was significantly more reduced in nGA eyes than in eyes with drusen alone, but no differences were seen when assessing other cone functions with normal luminance CS or LLVA

A retrospective analysis of 360 individuals identified several malignancy risk factors for plaque psoriasis patients.

The mean plasma Ctrough of roflumilast was 1.78 ng/mL, and 9.86 ng/mL for roflumilast N-oxide after 8 weeks of treatment.

An interview in which Dr. Lebwohl assessed the recent phase 3 trial data on itch treatment for psoriasis patients.

Dry AMD was more common than wet AMD, but visual acuity was more significantly affected in patients with wet AMD.

The implant significantly reduced CRT in patients with RVO-ME, but the study reported no relationship between OCT biomarkers and clinical outcomes.

Myopia progressed slower in the highly aspherical lenslet spectacle subset compared to single vision spectacles during the first 2 stages of the study.

Mixed emollients were effective in preventing infant atopic dermatitis development compared to standard care.

Research suggested no significant relationship between peanut sensitivity and AD severity as measured by two scores, although the study was acknowledged to have a smaller population due to pandemic restrictions.

The shared genetic structure and pleiotropic mechanisms in ocular diseases interprets their clinical associations to some extent, according to study authors.

New research on the TNF-alpha inhibitor infliximab as a treatment for PD-1-induced psoriasis demonstrated the treatment’s potential.

Both direct and indirect costs were higher in patients with mild-to-moderate and severe atopic dermatitis compared to the control group.

A recent analysis indicated the efficacy of 100 or 200 mg of tildrakizumab for moderate-to-severe plaque psoriasis patients.

The result show the gain in best-corrected visual acuity and the reduction in central subfield thickness at the conclusion of the core study was maintained up to week 24 of the extension study, with no differences in the safety profile.

A Q&A interview with Dr. Simpson regarding the recent INTEGUMENT clinical trial results regarding roflumilast for atopic dermatitis.

Despite its frequent use as a rescue therapy for patients with interstitial lung disease associated with connective tissue disorder, the effectiveness of rituximab hasn't been evaluated in many clinical trials.

Patients with sarcoidosis who practiced online mindfulness-based cognitive therapy (eMBCT) showed improvements in fatigue, anxiety, depression, and health status.

The findings may support the use of macular imaging for monitoring at the time of glaucoma diagnosis and for monitoring the rate of GCC thinning.

Neither the retinal disease nor the VEGF inhibitor type was significantly associated with rhegmatogenous retinal detachment risk.